Samben Pharma Private Limited - Company Profile

It is a business services private limited company based in Allahabad, Uttar Pradesh, India, established in 2023.
2023 Allahabad, Uttar Pradesh, India Active
Last Updated:
Access Report
About Samben Pharma Private Limited

Samben Pharma Private Limited, a active private limited company, was established on 31 May 2023 in Allahabad, Uttar Pradesh, India. it holds CIN: U46497UP2023PTC183150. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.

Its leadership includes Siddharth Shukla (Director), Saket Shukla (Director). It holds ₹1.40 Cr open charges and no settled loans. Its latest AGM occurred on 31 December 2024, with the balance sheet filed on 31 March 2024. It is based at 760/90A-1, Baghambari Roa, Allahabad, Uttar Pradesh, 211006.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497UP2023PTC183150

  • Registration Number

    183150

  • Incorporation Date

    31 May 2023

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹5.00 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 5.00 M
  • Company Age 2 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 1.40 Cr
Company report

Samben Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Samben Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Samben Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Siddharth Shukla Director 31 May 2023 Current
Saket Shukla Director 31 May 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Samben Pharma.

Enhance accessibility to Samben Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Samben Pharma revenue growth over time
Samben Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Samben Pharma?

Unlock access to Samben Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹14,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 1.40 Cr
Latest Charge Details
Date Lender Amount Status
03 Apr 2024 Others ₹1.40 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Samben Pharma?

Unlock and access historical data on people associated with Samben Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Samben Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samben Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Samben Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Samben Pharma Private Limited last Annual general meeting of members was held on 31 Dec 2024 as per latest MCA records. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 14.00 M with Charge ID 100910313 was registered on 03 Apr 2024. was documented.

  • Balance Sheet

    Progress on Samben Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.

  • Director Appointment

    Siddharth Shukla was appointed as a Director was appointed as a Director on 31 May 2023 & has been associated with this company since 2 years 8 months . was recorded as a recent event.

  • Director Appointment

    Saket Shukla was appointed as a Director was appointed as a Director on 31 May 2023 & has been associated with this company since 2 years 8 months . was recorded as a recent event.

  • Company Incorporation

    The activity Samben Pharma Private Limited was registered on 31 May 2023 with Roc Kanpur & aged 2 years 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Samben Pharma Private Limited?

The CIN of Samben Pharma Private Limited is U46497UP2023PTC183150.

Where is Samben Pharma Private Limited headquartered?

Samben Pharma Private Limited is headquartered at 760/90A-1, Baghambari Roa, Allahabad, Uttar Pradesh, 211006.

When was Samben Pharma Private Limited incorporated?

Samben Pharma Private Limited was incorporated on 31 May 2023.

Who are the current directors of Samben Pharma Private Limited?

The current directors of Samben Pharma Private Limited are

Is Samben Pharma Private Limited a listed company?

Samben Pharma Private Limited is unlisted.

What is the capital structure of Samben Pharma Private Limited?

The authorized capital of Samben Pharma Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available